• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT281412
Device Problem Insufficient Information (3190)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/13/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).A review of the manufacturing records for the device verified the lot met all pre-release specifications.
 
Event Description
The following information was reported to gore: on (b)(6) 2018 a patient was undergoing treatment of an abdominal aortic aneurysm with a gore® excluder® aaa endoprosthesis featuring c3® delivery system.Following initial deployment of the trunk-ipsilateral leg component, there was blood seen in the handle of the delivery system handle.The amount of blood was not significant and there were no adverse outcomes for the patient.The contralateral leg component was positioned and deployed and the case was completed with a successful outcome.The only issue was that the case was completed a little more hurriedly because of the bleeding.
 
Manufacturer Narrative
No udi information is available.Method code 1 updated results code 1 updated.A review of the manufacturing records could not be conducted since the lot number is unknown.The originally reported lot number was incorrect.H.6.Results code 2: 213: the engineering evaluation stated the following: the tuohy-borst valve appeared to be aligned with the spine and fully tightened.Engineering removed the spine covers and the spine was examined.No abnormalities were noted.The septum appeared to be intact with no obvious damage.Green dyed water was pressurized though the septum into the manifold area to determine the location of the leakage.Water was observed leaking out of the septum at what appears to be the constraining loop pre-formed hole.Based on the findings from this evaluation, the physician¿s observation that blood was seen in the handle of the delivery system handle was confirmed.The likely cause for the blood leaking from the delivery system handle could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8204256
MDR Text Key131744006
Report Number3007284313-2018-00372
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132622528
UDI-Public00733132622528
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 01/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/07/2021
Device Catalogue NumberRLT281412
Device Lot Number18447342
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/28/2018
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age60 YR
Patient Weight91
-
-